Alivexis, Inc.
PrivateLast Round
Series D
Mar 3, 2025
Total Funding Raised
$65.1M
Company Overview
Alivexis, Inc. is a biotechnology company that merges cutting-edge drug discovery platforms with disease biology expertise to develop a portfolio of small molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alivexis, Inc. Comparables
Compare Alivexis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 86% | |
| Aqemia | 83% | |
| Qubit Pharmaceuticals | 80% |
Alivexis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 3, 2025 | ||||
| Series D | Jan 7, 2025 | ||||
| Series C | Mar 1, 2022 | ||||
| Series B | May 13, 2020 | ||||
| Series A | Aug 9, 2018 |
Key People
Founding team and executive leadership
Alivexis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series C, Series B |
| Keio Innovation Initiative | Series C, Series B |
| Mizuho Capital | Series B |
| JIC Venture Growth Investments | Series D |
| Heights Capital Management | Series C |
| Mobile Internet Capital | Series B |
| Fast Track Initiative | Series D, Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 190% MoM, reaching 4.6K.
- Mar 11, 2025
Will present at the GTC 2025 japan AI day event.
Alivexis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alivexis, Inc.'s valuation, stock price, and market status.
Is Alivexis, Inc. a public or private company?
Alivexis, Inc. is a private company.
What is the current stock price of Alivexis, Inc.?
Alivexis, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Alivexis, Inc. worth (valuation)?
Valuation information for Alivexis, Inc. is not publicly available.
Can I buy Alivexis, Inc. stock?
Alivexis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alivexis, Inc.'s last funding round?
Alivexis, Inc.'s most recent funding round was Series D on March 3, 2025.
Who are the main investors in Alivexis, Inc.?
Key investors in Alivexis, Inc. include Fast Track Initiative, SBI Holdings.
Will Alivexis, Inc. IPO soon?
No public IPO plans have been announced for Alivexis, Inc..
How can I track Alivexis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alivexis, Inc.'s secondary market activity and sign up for updates.